Adma Biologics: 2Q Earnings Snapshot
RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Friday reported a loss of $14.7 million in its second quarter.
On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 35 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The infectious disease drug developer posted revenue of $4.7 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $5.4 million.
Adma Biologics shares have increased 96 percent since the beginning of the year. The stock has more than doubled in the last 12 months.